These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1565570)

  • 1. [L-18F-dopa-PET in Parkinson-plus syndromes for the detection of a disordered presynaptic dopaminergic function].
    Cordes M; Snow BJ; Takahashi H; Schofield P; Cooper S; Sossi V; Morrison S; Calne DB
    Nuklearmedizin; 1992 Mar; 31(2):43-7. PubMed ID: 1565570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
    Cordes M; Poewe W
    Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
    Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigrofrontal dopaminergic function as assessed by 18F-dopa PET.
    Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Yoshida T; Fukumura T; Masuda K
    Nucl Med Commun; 1995 Dec; 16(12):1021-5. PubMed ID: 8719983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy.
    Cordes M; Snow BJ; Morrison S; Sossi V; Ruth TJ; Calne DB
    Neuroradiology; 1993; 35(6):404-9. PubMed ID: 8377907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography in Shy-Drager syndrome.
    Bhatt MH; Snow BJ; Martin WR; Cooper S; Calne DB
    Ann Neurol; 1990 Jul; 28(1):101-3. PubMed ID: 2375624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study.
    Ito K; Nagano-Saito A; Kato T; Arahata Y; Nakamura A; Kawasumi Y; Hatano K; Abe Y; Yamada T; Kachi T; Brooks DJ
    Brain; 2002 Jun; 125(Pt 6):1358-65. PubMed ID: 12023324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional imaging for disorders of basal ganglia].
    Otsuka M; Taniwaki T
    Rinsho Shinkeigaku; 1999 Jan; 39(1):30-2. PubMed ID: 10377793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in progressive supranuclear palsy.
    Bhatt MH; Snow BJ; Martin WR; Peppard R; Calne DB
    Arch Neurol; 1991 Apr; 48(4):389-91. PubMed ID: 1901484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptor imaging and measurement with SPECT.
    Brücke T; Wenger S; Asenbaum S; Fertl E; Pfafflmeyer N; Müller C; Podreka I; Angelberger P
    Adv Neurol; 1993; 60():494-500. PubMed ID: 8420177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow.
    Bhatt MH; Snow BJ; Martin WR; Pate BD; Ruth TJ; Calne DB
    Ann Neurol; 1991 Jun; 29(6):673-7. PubMed ID: 1892369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic cardioneuropathy in dysautonomias.
    Goldstein DS; Holmes C; Cannon RO; Eisenhofer G; Kopin IJ
    N Engl J Med; 1997 Mar; 336(10):696-702. PubMed ID: 9041100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
    Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
    Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET studies on the early and differential diagnosis of Parkinson's disease.
    Brooks DJ
    Neurology; 1993 Dec; 43(12 Suppl 6):S6-16. PubMed ID: 8264913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic cardioneuropathy in dysautonomias.
    Goldstein DS; Holmes C; Cannon RO; Eisenhofer G; Kopin IJ
    Adv Pharmacol; 1998; 42():615-9. PubMed ID: 9327977
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine.
    Doudet DJ; Chan GL; Jivan S; DeJesus OT; McGeer EG; English C; Ruth TJ; Holden JE
    J Cereb Blood Flow Metab; 1999 Mar; 19(3):278-87. PubMed ID: 10078880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positron emission tomography and basal ganglia functions].
    Kato M
    No To Shinkei; 1990 May; 42(5):450-60. PubMed ID: 2206633
    [No Abstract]   [Full Text] [Related]  

  • 18. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.
    Snow BJ; Nygaard TG; Takahashi H; Calne DB
    Ann Neurol; 1993 Nov; 34(5):733-8. PubMed ID: 8239569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations.
    Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Zanzi I; Mandel F; Spetsieris P; Eidelberg D
    J Nucl Med; 1994 Jun; 35(6):955-63. PubMed ID: 8195882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.